Congress Asset Management Co. Raises Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Congress Asset Management Co. raised its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 16.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 118,941 shares of the company’s stock after buying an additional 17,127 shares during the quarter. Congress Asset Management Co. owned about 0.13% of Acadia Healthcare worth $7,542,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the business. Blue Trust Inc. grew its holdings in shares of Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after buying an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Acadia Healthcare during the 2nd quarter valued at $59,000. DekaBank Deutsche Girozentrale bought a new stake in shares of Acadia Healthcare during the 3rd quarter worth $86,000. Finally, nVerses Capital LLC bought a new position in Acadia Healthcare in the second quarter valued at $95,000.

Acadia Healthcare Stock Performance

Shares of NASDAQ:ACHC opened at $42.69 on Friday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60. The company has a 50-day moving average price of $67.15 and a 200-day moving average price of $68.18. The company has a market cap of $3.96 billion, a price-to-earnings ratio of 14.00, a price-to-earnings-growth ratio of 1.57 and a beta of 1.29. Acadia Healthcare Company, Inc. has a 12 month low of $42.46 and a 12 month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The business had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same quarter in the prior year, the company posted $0.91 EPS. Acadia Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ACHC. Deutsche Bank Aktiengesellschaft upped their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. KeyCorp assumed coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Barclays lowered their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday, September 30th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a report on Friday, September 20th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $86.67.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.